Integra LifeSciences Holdings (NASDAQ: IART) entered into a definitive agreement with Covidien (NYSE: COV) to acquire the Confluent Surgical product ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE